Skip to content
Intelligence IAMay 15, 2026Intelligence IA
Article

Citius Oncology reported positive progress in the launch of LYMPHIR®.

First-half fiscal 2026 revenue reached $5.6 million, with broad payer coverage already established.

Redaction Data Cube AISource: PR Newswire
01

Brief source

Citius Oncology reported positive progress in the launch of LYMPHIR®. First-half fiscal 2026 revenue reached $5.6 million, with broad payer coverage already established.